These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20723009)

  • 1. Inhibitory effects of uraemic toxins 3-indoxyl sulfate and p-cresol on losartan metabolism in vitro.
    Tsujimoto M; Higuchi K; Shima D; Yokota H; Furukubo T; Izumi S; Yamakawa T; Otagiri M; Hirata S; Takara K; Nishiguchi K
    J Pharm Pharmacol; 2010 Jan; 62(1):133-8. PubMed ID: 20723009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin.
    Choi DH; Li C; Choi JS
    J Pharm Pharmacol; 2010 Jul; 62(7):908-14. PubMed ID: 20636879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of uremic serum and uremic toxins on drug metabolism in human microsomes.
    Volpe DA; Tobin GA; Tavakkoli F; Dowling TC; Light PD; Parker RJ
    Regul Toxicol Pharmacol; 2014 Mar; 68(2):297-303. PubMed ID: 24184159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin.
    Tsujimoto M; Hatozaki D; Shima D; Yokota H; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Ther Apher Dial; 2012 Dec; 16(6):580-7. PubMed ID: 23190519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
    Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
    J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
    Deguchi T; Ohtsuki S; Otagiri M; Takanaga H; Asaba H; Mori S; Terasaki T
    Kidney Int; 2002 May; 61(5):1760-8. PubMed ID: 11967025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal disease.
    Tsujimoto M; Nagano Y; Hosoda S; Shiraishi A; Miyoshi A; Hiraoka S; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Toxins (Basel); 2013 Aug; 5(8):1475-85. PubMed ID: 23965431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.
    Lee CT; Kuo CC; Chen YM; Hsu CY; Lee WC; Tsai YC; Ng HY; Kuo LC; Chiou TT; Yang YK; Cheng BC; Chen JB
    Perit Dial Int; 2010; 30(4):456-63. PubMed ID: 20338972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of licochalcon A on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats.
    Choi JS; Choi JS; Choi DH
    Pharmazie; 2013 Nov; 68(11):882-8. PubMed ID: 24380237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
    Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
    Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Metabolism Interaction Between p-Cresol and Mycophenolic Acid.
    Rong Y; Kiang TKL
    Toxicol Sci; 2020 Feb; 173(2):267-279. PubMed ID: 31742356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of protein-bound uraemic toxins by haemodialysis.
    Niwa T
    Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of uremic serum and uremic toxins on hepatic uptake of digoxin.
    Tsujimoto M; Kinoshita Y; Hirata S; Otagiri M; Ohtani H; Sawada Y
    Ther Drug Monit; 2008 Oct; 30(5):576-82. PubMed ID: 18708994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive simultaneous quantification of indoxyl sulfate and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry.
    Oda A; Suzuki Y; Sato B; Sato H; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Sep Sci; 2022 May; 45(10):1672-1682. PubMed ID: 35247297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky.
    Evenepoel P; Glorieux G; Meijers B
    Kidney Int; 2017 Dec; 92(6):1323-1324. PubMed ID: 29153138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.
    Lesaffer G; De Smet R; Lameire N; Dhondt A; Duym P; Vanholder R
    Nephrol Dial Transplant; 2000 Jan; 15(1):50-7. PubMed ID: 10607767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-bound uremic toxins induce tissue remodeling by targeting the EGF receptor.
    Sun CY; Young GH; Hsieh YT; Chen YH; Wu MS; Wu VC; Lee JH; Lee CC
    J Am Soc Nephrol; 2015 Feb; 26(2):281-90. PubMed ID: 25012179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
    Shafi T; Sirich TL; Meyer TW; Hostetter TH; Plummer NS; Hwang S; Melamed ML; Banerjee T; Coresh J; Powe NR
    Kidney Int; 2017 Dec; 92(6):1484-1492. PubMed ID: 28739139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.